Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ABBV - I-MAB BioPharma And Its Dual Drug Portfolio

ABBV - I-MAB BioPharma And Its Dual Drug Portfolio

AbbVie Inc.
  • I-MAB BioPharma is a new player in the global pharmaceuticals market with autoimmune products.
  • It has a robust portfolio of marketable drugs with several more in the pipeline.
  • The company has global partnerships and an international footprint that will expand drastically as its newer products reach the market.
  • I-MAB has a dual focus offering distinctive business strategies for both China and the world at large.

For further details see:

I-MAB BioPharma And Its Dual Drug Portfolio
Stock Information
Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvieinvestor.com
Menu
ABBV ABBV Quote ABBV Short ABBV News ABBV Articles ABBV Message Board
Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...